US EditionJoel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88
2 Articles
2 Articles
Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88
Joel Habener, an American endocrinologist who discovered GLP-1, the protein fragment that became the basis of Ozempic, Wegovy and other blockbuster weight-loss and diabetes drugs that are transforming 21st-century medicine, died on Dec. 28 in Newton, Mass. He was 88. His death, in a retirement community, was confirmed by his brother, Stephen, who said the cause was a heart attack. Researchers and drug companies long tried and failed to find an e…
Joel Habener, an American endocrinologist who discovered the GLP-1 — a protein fragment that caused Ozempic, Wegovy and other drugs of great success against obesity and diabetes that are transforming the medicine of the 21st century — died on December 28, Newton, in the state of Massachusetts. He was 88 years old. He died in a house of rest and was confirmed by his brother, Stephen, who reported that the cause was a heart attack. For decades, re…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
